| Autor: |
Shirey KA; Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA., Lai W; Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA., Pletneva LM; Sigmovir Biosystems, Inc., Rockville, Maryland, USA., Karp CL; Division of Cellular and Molecular Immunology, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio, USA., Divanovic S; Division of Cellular and Molecular Immunology, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio, USA., Blanco JC; Sigmovir Biosystems, Inc., Rockville, Maryland, USA., Vogel SN; Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA. |
| Abstrakt: |
Resolution of severe Respiratory Syncytial Virus (RSV)-induced bronchiolitis is mediated by alternatively activated macrophages (AA-Mφ) that counteract cyclooxygenase (COX)-2-induced lung pathology. Herein, we report that RSV infection of 5-lipoxygenase (LO)(-/-) and 15-LO(-/-) macrophages or mice failed to elicit AA-Mφ differentiation and concomitantly exhibited increased COX-2 expression. Further, RSV infection of 5-LO(-/-) mice resulted in enhanced lung pathology. Pharmacologic inhibition of 5-LO or 15-LO also blocked differentiation of RSV-induced AA-Mφ in vitro and, conversely, treatment of 5-LO(-/-) macrophages with downstream products, lipoxin A4 and resolvin E1, but not leukotriene B4 or leukotriene D4, partially restored expression of AA-Mφ markers. Indomethacin blockade of COX activity in RSV-infected macrophages increased 5-LO and 15-LO, as well as arginase-1 mRNA expression. Treatment of RSV-infected mice with indomethacin also resulted not only in enhanced lung arginase-1 mRNA expression and decreased COX-2, but also decreased lung pathology in RSV-infected 5-LO(-/-) mice. Treatment of RSV-infected cotton rats with a COX-2-specific inhibitor resulted in enhanced lung 5-LO mRNA and AA-Mφ marker expression. Together, these data suggest a novel therapeutic approach for RSV that promotes AA-Mφ differentiation by activating the 5-LO pathway. |
